N
TYRA icon

Nuveen’s Tyra Biosciences TYRA Stock Holding History

Nuveen’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Buy
50,840
+3,491
+7% +$113K ﹤0.01% 2289
2025
Q4 		$1.24M Sell
47,349
-33,092
-41% -$608K ﹤0.01% 2507
2025
Q3 		$1.13M Hold
80,441
– – ﹤0.01% 2562
2025
Q2 		$770K Buy
80,441
+30,443
+61% +$289K ﹤0.01% 2715
2025
Q1 		$465K Hold
49,998
– – ﹤0.01% 2924
2024
Q4 		$695K Hold
49,998
– – ﹤0.01% 2859
2024
Q3 		$1.18M Sell
49,998
-42,660
-46% -$896K ﹤0.01% 2686
2024
Q2 		$1.48M Buy
92,658
+66,945
+260% +$1.15M ﹤0.01% 2528
2024
Q1 		$422K Hold
25,713
– – ﹤0.01% 3023
2023
Q4 		$356K Buy
25,713
+6,957
+37% +$90.1K ﹤0.01% 3106
2023
Q3 		$258K Hold
18,756
– – ﹤0.01% 2990
2023
Q2 		$319K Hold
18,756
– – ﹤0.01% 3008
2023
Q1 		$301K Hold
18,756
– – ﹤0.01% 2918
2022
Q4 		$143K Hold
18,756
– – ﹤0.01% 3079
2022
Q3 		$165K Hold
18,756
– – ﹤0.01% 3127
2022
Q2 		$134K Buy
18,756
+356
+2% +$2.83K ﹤0.01% 3179
2022
Q1 		$197K Hold
18,400
– – ﹤0.01% 3196
2021
Q4 		$259K Buy
+18,400
New +$366K ﹤0.01% 3199

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Nuveen's TYRA Position: Q1 2026 in Review

Nuveen increased its Tyra Biosciences (TYRA) stake by 7.4% in Q1 2026, buying an estimated $113K and bringing the position to 50,840 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Nuveen first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Nuveen held 50,840 shares of Tyra Biosciences worth $1.95M as of Q1 2026.
  • Nuveen bought 3,491 Tyra Biosciences shares in Q1 2026, an estimated $113K.
  • Tyra Biosciences made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2289 holding.
  • Nuveen first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.